MarketInOut Stock Screener Log In | Sign Up
 

Iridex Corp

NASDAQ • Healthcare • Medical Devices • Quote as of 10/23/2026
Iridex Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization13.1 mln
Float10.86 mln
Earnings Date11/17/2026

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

-3.06
Reliable

Relative Strength

16 / 100
Significantly lagging

Debt / Equity

1.10
Elevated leverage

Pre-Tax Margin

-7%
Marginally loss-making

ROE

-73.79
Deeply negative

Business Description

IRIDEX Corporation develops and sells laser-based medical systems designed to treat serious eye conditions such as glaucoma, diabetic retinopathy, and retinal tears. Its product range includes laser consoles, handheld and slit lamp delivery devices, and single-use instruments used by eye doctors in clinics, hospitals, surgical centers, and research facilities. Founded in 1989 and based in Mountain View, California, the company sells its products both directly and through independent distributors across the United States and in markets spanning Europe, the Middle East, Africa, Asia-Pacific, and the Americas.

Key Fundamentals

EPS-0.19
ROE-73.79
RPS2.99
ROIC-16.12
ROA-12.26
EBITDA, mln-1.87
EV / EBITDA-8.74
EV / EBIT-4.82
Revenue, mln51.57
EV / Revenue0.32

Quote Details

Last 0.7457
Change -0.0166 (-2.18%)
Open 0.74
Volume 18,982
Turnover 14,155
Average Volume 937,167

Financial Ratios

Pre-Tax Profit Margin-7
Leverage Ratio7.49
Current Ratio1.82
Price / Book3.56
Debt / Equity1.10
Price / Sales0.21
PEG Ratio0.94

Financial Strength

Altman Z-Score-2.6
Piotroski F-Score 3 / 9
Beneish M-Score-3.06
Short Ratio2.66
Short % of Float1.18

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -8.46% 11 / 100   
1 Month 18.37% 96 / 100   
2 Months -19.44% 23 / 100   
6 Months -29.65% 21 / 100   
1 Year -29.65% 26 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog